Cdc19 amyloid core peptide is a specific short peptide sequence. Cdc19 amyloid core peptide forms stable, reversible amyloid fibrils, whose protofibrils are twisted in a regular cross-point arrangement and possess a cross-beta structure. Structurally, Cdc19 amyloid core peptide is similar to irreversible pathological amyloid proteins associated with neurodegenerative diseases, metabolic disorders and cancer, while it also has important physiological functions related to cell survival. Cdc19 amyloid core peptide can be used in the research of neurodegenerative diseases (Alzheimers disease and Parkinsons disease)[1].
Molekulargewicht:
1654.77
Formel:
C71H115N17O28
Target-Kategorie:
Amyloid-beta
Anwendungsbeschreibung:
MCE Product type: Peptides
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
